SCHEMBL580352

SCHEMBL580352

F[C](F)c1cccc(F)c1F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 6/20 0.62
CES1 P23141 6/20 0.62
BCHE P06276 1/20 0.62
HPGD P15428 2/20 0.47
ALB P02768 1/20 0.41
KAT6A Q92794 2/20 0.40
ALDH1A1 P00352 2/20 0.39
ALOX15 P16050 1/20 0.39
ATM Q13315 1/20 0.37
GAA P10253 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CTSL P07711 1/20 0.34
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
P2RX7 Q99572 1/20 0.33
PTPN1 P18031 1/20 0.32
ERCC5 P28715 1/20 0.32
FEN1 P39748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31537534 0.80 CES2 (0.71) CES2CES1BCHEHPGDALB
SCHEMBL6441124 0.80 CES2 (0.71) CES2CES1BCHEHPGDALB
SCHEMBL22540 0.80 CES2 (0.58) CES2CES1BCHEHPGDALB
SCHEMBL5845101 0.78 CES2 (0.56) CES2CES1BCHEHPGDALB
SCHEMBL489916 0.78 CES2 (0.59) CES2CES1BCHEHPGDALB
SCHEMBL16953030 0.77 CES2 (0.60) CES2CES1BCHEHPGDALB
SCHEMBL3184940 0.77 CES2 (1.00) CES2CES1BCHEHPGDALB
SCHEMBL3440833 0.77 CES2 (0.74) CES2CES1BCHEHPGDALB
SCHEMBL28557442 0.77 CES2 (0.54) CES2CES1BCHEHPGDALB
SCHEMBL15920914 0.77 CES2 (0.54) CES2CES1BCHEHPGDALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023160316-A1 PYRETHROID COMPOUND CONTAINING DOUBLE BONDS AND CYANO GROUPS, SYNTHESIS METHOD THEREFOR, AND APPLICATION THEREOF 江苏扬农化工股份有限公司 2023-08-31 WO claimed
CN-116375604-A Double-bond cyano-containing pyrethroid compound, and synthetic method and application thereof 江苏扬农化工股份有限公司 2023-07-04 CN claimed
CN-111362962-A Tetrafluorobenzyl norcantharidin carboxylate and synthesis method thereof 遵义医科大学 2020-07-03 CN claimed
EP-2922401-B1 USE OF A COMPOUND COMPRISING A POLYFLUOROBENZYL MOIETY AGAINST INSECTICIDE-RESISTANT BED-BUGS BAYER CROPSCIENCE AG (DE) 2018-04-25 EP claimed
EP-2417972-B1 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING BURN INJURIES NEUROTECH PHARMACEUTICALS CO LTD (KR) 2017-06-14 EP claimed
EP-1551793-B1 TETRAFLUOROBENZYL DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ACUTE AND CHRONIC NEURODEGENERATIVE DISEASES IN CENTRAL NERVOUS SYSTEM CONTAINING THE SAME AMKOR PHARMA INC (US) 2016-01-20 EP claimed
US-20120301551-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION NEUROTECH PHARMACEUTICALS CO., LTD. (KR) 2012-11-29 US claimed
US-20120289602-A1 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING BURN INJURIES ARAONTECH CO., LTD. (KR) 2012-11-15 US claimed
CN-102421430-A Pharmaceutical composition for treating or preventing burn NEUROTECH PHARMACEUTICALS CO L 2012-04-18 CN claimed
EP-2417972-A2 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING BURN INJURIES Neurotech Pharmaceuticals Co., Ltd. (KR) 2012-02-15 EP claimed
CN-1738627-A Method for inhibiting necrosis induced by neurotrophic factor NEUROTECH PHARMACEUTICALS CO L (KR) 2006-02-22 CN claimed
EP-1592429-A1 METHOD FOR INHIBITION OF NECROSIS INDUCED BY NEUROTROPHIN Neurotech Pharmaceuticals Co., Ltd. (KR) 2005-11-09 EP claimed
US-20050239896-A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same NEUROTECH CO., LTD 2005-10-27 US claimed
CN-1668576-A Tetrafluorobenzyl derivatives and pharmaceutical composition for treating and preventing acute and chronic neurodegenerative diseases of central nervous system containing the same NEUROTECH CO LTD (KR) 2005-09-14 CN claimed
WO-2004064844-A9 METHOD FOR INHIBITION OF NECROSIS INDUCED BY NEUROTROPHIN NEUROTECH PHARMACEUTICALS CO L (KR) 2005-08-25 WO claimed
US-6927303-B2 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same NEUROTECH CO., LTD. (KR) 2005-08-09 US claimed
EP-1551793-A1 TETRAFLUOROBENZYL DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ACUTE AND CHRONIC NEURODEGENERATIVE DISEASES IN CENTRAL NERVOUS SYSTEM CONTAINING THE SAME Neurotech Co., Ltd. (KR) 2005-07-13 EP claimed
US-20040209957-A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same NEUROTECH PHARMACEUTICALS CO., LTD. (KR) 2004-10-21 US claimed
WO-2004064844-A1 METHOD FOR INHIBITION OF NECROSIS INDUCED BY NEUROTROPHIN NEUROTECH PHARMACEUTICALS CO., LTD. (KR) 2004-08-05 WO claimed
WO-2004000786-A1 TETRAFLUOROBENZYL DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ACUTE AND CHRONIC NEURODEGENERATIVE DISEASES IN CENTRAL NERVOUS SYSTEM CONTAINING THE SAME NEUROTECH CO., LTD. (KR) 2003-12-31 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120301551-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION BCL2, BAX, SMN1; SMN2 CES2 3610/4885CES1 4585/4885BCHE 1012/4885
US-20050239896-A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same HTT, BDNF, APP CES2 2830/4885CES1 2683/4885BCHE 122/4885
US-20120289602-A1 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING BURN INJURIES CTSA, CFTR, CPT1A CES2 996/4885CES1 346/4885BCHE 688/4885
US-20040209957-A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same HTT, BDNF, APP CES2 2830/4885CES1 2683/4885BCHE 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.